DOSE OF REALITY: FORBES: MAKING IT HARDER TO CHALLENGE BIG PHARMA’S PATENT THICKETS WOULD RAISE DRUG PRICES, UNDERMINE TRUE INNOVATION
Research Article Explores Negative Implications of Proposal to Restrict Key… Read More

Research Article Explores Negative Implications of Proposal to Restrict Key… Read More
Research Column Explores Case Study in Common Patent Abuse Tactic That… Read More
Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold… Read More
Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on… Read More
Analysis Shows Price Hikes Outpacing Inflation, Rising Launch Prices and… Read More
Reports Find Biosimilars Have Lower Prices Than Brand Name Biologics… Read More
Two Reports Explore Cost for U.S. Patients and the U.S. Health Care System of… Read More
CBO Says Cost to Taxpayers of Covering GLP-1 Medications Would Outpace Savings… Read More
Patent Abuse Designed to Extend Monopolies, Block Competition and Keep Prices… Read More
JAMA Analysis Finds Patents for Active Ingredients for Weight Loss Drugs… Read More
Big Pharma Price Hikes, Rising Launch Prices And Patent Abuse Impose Massive… Read More
Report Finds Big Pharma Increased Spending on R&D in First Half of 2023,… Read More